Study on effect of lentinan in enhancing anti-tumor action of dendritic cytoma vaccine and its mechanism / 中国中西医结合杂志

ABSTRACT

<p><b>OBJECTIVE</b>To improve the anti-tumor effect of dendritic cytoma vaccine (DCV) for finding an effective anti-tumor biotherapy.</p><p><b>METHODS</b>DC vaccine prepared by transfection of adenovirus mediated melanoma-associated antigen gene (gp100) into bone marrow-derived dendritic cell (DC) was used to study the immuno-therapeutic effect and the mechanism of lentinan (LNT) in different dosages, used alone or combined with gp100-DC for treatment of B16 melanoma bearing mice.</p><p><b>RESULTS</b>After being treated with LNT combining gp100-DC, the growth of malignant melanoma was inhibited with the tumor-free survival in the experimental animals being 66.7%. The treatment could also significantly enhance the activity of cytotoxicity T lymphocyte (CTL) and natural killer (NK) cells, elevate the levels of interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) in splenocytes, and histological examination showed that a large amount of inflammatory cells infiltrated inside and around the tumor, and obvious necrosis of tumor cells was found.</p><p><b>CONCLUSION</b>By combined use with LNT the anti-tumor immuno-reaction of DCV vaccine could be enhanced effectively.</p>